In a filing, Amneal Pharmaceuticals Inc revealed its Director Patel Gautam unloaded Company’s shares for reported $0.65 million on Feb 03 ’25. In the deal valued at $8.14 per share,80,000 shares were sold. As a result of this transaction, Patel Gautam now holds 1,888,886 shares worth roughly $16.06 million.
Then, Patel Gautam sold 62,590 shares, generating $501,346 in total proceeds. Upon selling the shares at $8.01, the Director now owns 1,968,886 shares.
Before that, Patel Gautam sold 17,410 shares. Amneal Pharmaceuticals Inc shares valued at $139,454 were divested by the Director at a price of $8.01 per share. As a result of the transaction, Patel Gautam now holds 2,031,476 shares, worth roughly $17.27 million.
JP Morgan upgraded its Amneal Pharmaceuticals Inc [AMRX] rating to an Overweight from a a Neutral in a research note published on February 24, 2025; the price target was increased to $12 from $9. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early September from “an Underweight” to “a Neutral”. Goldman revised its rating on March 08, 2021. It rated AMRX as “a Buy” which previously was an “a Sell”.
Price Performance Review of AMRX
On Tuesday, Amneal Pharmaceuticals Inc [NASDAQ:AMRX] saw its stock jump 2.41% to $8.50. Over the last five days, the stock has gained 9.11%. Amneal Pharmaceuticals Inc shares have risen nearly 7.32% since the year began. Nevertheless, the stocks have risen 49.38% over the past one year. While a 52-week high of $9.48 was reached on 01/23/25, a 52-week low of $5.01 was recorded on 01/07/25. SMA at 50 days reached $8.05, while 200 days put it at $7.86.
Levels Of Support And Resistance For AMRX Stock
The 24-hour chart illustrates a support level at 8.34, which if violated will result in even more drops to 8.19. On the upside, there is a resistance level at 8.58. A further resistance level may holdings at 8.67. The Relative Strength Index (RSI) on the 14-day chart is 62.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.22%. Stochastics %K at 54.03% indicates the stock is a holding.
